We report the clinicopathologic features of 2 unrelated patients with sporadic amyotrophic lateral sclerosis (SALS) supported by tracheostomy and invasive ventilation (TIV) who were able to maintain communication ability for more than 30 years after disease onset. In both cases, the age at onset was younger than the mean, initially the progression of muscle weakness was consistent with that in the majority of SALS patients, and TIV became necessary several years after disease onset. Thereafter, however, their neurologic deterioration slowed and the patients were able to operate computers by facial movements for several decades. At autopsy, neuronal loss appeared to be confined to the motor neuron system. Furthermore, while Betz cells and lower motor neurons in the spinal anterior horns and hypoglossal nucleus were severely depleted, other pyramidal neurons in the motor cortex, and lower motor neurons in the other brainstem motor nuclei were retained. Neuronal and glial cytoplasmic inclusions immunoreactive for phosphorylated 43-kDa TAR DNAbinding protein (TDP-43) were evident in the CNS, but in extremely small numbers. The present patients may represent a distinct subgroup of patients with SALS who are able to maintain communication ability for an extremely long period, accompanied by very mild TDP-43 pathology.
INTRODUCTION
Sporadic amyotrophic lateral sclerosis (SALS) is a fatal, progressive neurodegenerative disorder characterized principally by progressive muscular weakness due to degeneration of both the upper and lower motor neuron systems (1) . Since the identification of 43-kDa TAR DNA-binding protein (TDP-43) as the major component of the characteristic ubiquitinated inclusions, SALS has been regarded as one of the representative TDP-43 proteinopathies (2, 3) . Overall, the median survival time of patients with SALS is about 32 months unless they receive artificial ventilation support (4) , and death due to respiratory failure comes to most patients within 5 years after disease onset (4) . Tracheostomy and invasive ventilation (TIV) can extend the survival time of SALS patients for years, but the median survival time in such cases is nevertheless 74 months (4) . Moreover, approximately 11%-24% of patients lose all voluntary movements including eye movement and enter a totally locked-in state at around 70-80 months after initiation of TIV (5, 6) . Therefore, even for patients with SALS receiving TIV, long-term survival for several decades while maintaining communication ability is quite rare, and to our knowledge, only one such patient with SALS-TDP has been reported (7) .
Neuropathologic studies of patients with SALS resulting in a totally locked-in state have revealed severe multisystem degeneration accompanied by widespread and abundant TDP-43-immunoreactive (ir) inclusions (8) . On the other hand, we have previously reported the clinicopathologic features of SALS patients who survived for more than 10 years without TIV, in whom the degeneration was confined to the motor neuron system and TDP-43-ir inclusions were small in number and distributed in restricted areas (9) . On the basis of these findings, it is speculated that SALS patients on TIV who maintain communication ability for a markedly extended period may show characteristic features similar to patients who survive for more than 10 years without TIV. However, it is not clear whether these 2 groups show identical histopathologic features. Here we describe the clinicopathologic features of 2 autopsied patients with SALS-TDP who had been supported by TIV, and who survived for more than 30 years after disease onset while maintaining communication ability throughout the clinical course. We compare their clinicopathologic features with those of SALS-TDP patients who had survived for more than 10 years without TIV.
Case Histories
Patient 1, a 41-year-old woman, developed a nasal voice, dysarthria, and dysphagia, which slowly worsened and was soon accompanied by exertional dyspnea. Neurologic examination revealed mild atrophy and fasciculation of the tongue, poor movement of the soft plate, mild weakness of the neck muscles, and diffuse and mild hyperreflexia including jaw jerk. No pathologic reflexes were detected, and no sensory or autonomic disturbance, or cognitive impairment was evident. Electromyography revealed denervation in the tongue, but not in the biceps brachii muscle. Amyotrophic lateral sclerosis (ALS) was suspected. The muscle weakness progressed slowly and involved the upper extremities initially, and then the lower ones. The patient became wheelchair-bound around the age of 44 years, and TIV and tube feeding were introduced at the age of 47 and 48 years, respectively. At the age of 65 years she became bedridden with no voluntary movement in her limbs. However, she was still able to take a small amount of liquid food by mouth, and communicate via eye movements. Her cognitive function was well preserved, as she was able to write articles with the aid of a personal computer operated by forehead movements. Her disease progressed extremely slowly, and she remained able to communicate via eye and mandibular movements until the end of her life. She died of liver failure at the age of 78 years.
Patient 2, a 38-year-old man, developed bilateral lower limb weakness, and spasm in the left lower limb. Neurologic examination revealed muscle atrophy and fasciculation in the upper limbs, diffuse hyperreflexia including jaw jerk, and extensor plantar responses. No sensory or autonomic disturbance, or cognitive impairment was noted. Electromyography revealed extensive denervation in the upper and lower extremity muscles. He was diagnosed as having motor neuron disease. His muscle weakness progressed gradually, and he became unable to walk independently at the age of 40. Tube feeding and TIV were introduced at the age of 42 years. By the age of 56 years, he had become totally quadriplegic, but his eye movements, facial expression, and cognitive function were well preserved, and he was able to communicate via a personal computer using mandibular movements, and read and write sentences on a screen. Thereafter, his motor function remained stable until the end of his life. He died of pulmonary alveolar proteinosis at the age of 69 years.
No dementia was noted in either of the patients, although patient 1 developed depression at the age of 70 years. Neither of the patients had a family history of neurologic disorders; there were no mutations in the TARDBP, SOD1, and TBK1 genes, there was no expansion of C9ORF72 hexanucleotide repeats, and no expansion of polyglutamine repeats in the ATXN2 gene.
MATERIALS AND METHODS
Autopsy of patients 1 and 2 was performed 2 and 3 hours, respectively, after death. Histologic examinations of the CNS were performed by making multiple, formalin-fixed, paraffinembedded tissue blocks, and 4-lm-thick sections were stained with hematoxylin and eosin, and by the Klüver-Barrera method. The sections were also subjected to immunohistochemistry using mouse monoclonal antibodies against phosphorylated TDP-43 (pS409/410; clone 11-9; Cosmo Bio Co., Ltd., Tokyo, Japan; diluted 1:5000, pretreated by heating), p62 lck ligand (clone 3/P62 LCK LIGND; BD Biosciences, San Jose, CA; 1:1000, pretreated by heating), CD68 (clone 514H12; Leica Biosystems, Newcastle-upon-Tyne, UK; 1:50, pretreated by heating), rabbit polyclonal antibodies against cystatin C (Dako, Glostrup, Denmark; 1:4000), FUS (SigmaAldrich, St. Louis, MO; 1:50, pretreated by heating), GFAP (Dako, 1:1500), and Iba1 (Wako, Osaka, Japan; 1:2000, pretreated by heating). The spinal anterior roots at the cervical level in both patients were fixed in 20% buffered formalin, postfixed in 1% osmium tetroxide, and embedded in Epon 812. They were sectioned at 1-lm thickness and stained with toluidine blue. The present study was approved by the institutional review board of Niigata University School of Medicine, Niigata, Japan.
RESULTS
The histopathologic features of the CNS in patients 1 and 2 were quite similar. Their brains, showing mild atrophy of the precentral gyrus, weighed 1100 and 1150 g, respectively. Microscopically, the motor cortex from the medial to the lateral side, showed almost complete loss of Betz cells, although surprisingly loss of other pyramidal neurons and gliosis were mild ( Fig. 1A -C, E). Furthermore, immunostaining for GFAP revealed mild gliosis (Fig. 1D ). In the motor cortex, there were no evident features indicating ongoing neuronal degeneration, including neuronophagia (10), CD68-ir-macrophage infiltration, or Iba1-ir microglia activation. The spinal cord showed degeneration of the corticospinal tracts from the cervical to the sacral level, although apparently mild in degree (Fig. 1F , G). The spinal anterior horn (Fig. 1H ) and the hypoglossal nucleus showed marked neuronal loss with gliosis, whereas the trigeminal motor nucleus (Fig. 1I) , facial nucleus, and ambiguus nucleus (Fig. 1J) showed only mild to moderate neuronal loss. No active degenerative features, including neuronophagia, macrophage infiltration, and microglia activation, were evident in these brainstem motor nuclei, spinal anterior horns, or corticospinal tracts. No degeneration was evident in other CNS areas beyond the primary and secondary motor areas. Several Bunina bodies and cystatin C-ir inclusions considered to be Bunina bodies were evident in the trigeminal motor nucleus and cerebellar dentate nucleus in patient 1 (Fig. 1K-M) , but no such inclusions were observed in patient 2. Phosphorylated TDP-43 (pTDP-43) immunohistochemistry revealed neuronal (Fig. 1N, O) and glial ( J (Fig. 1O ), but not round in shape. Most of the glial cells possessing pTDP-43-ir cytoplasmic inclusions were oligodendrocytes. The number of NCIs and GCIs was extremely small, even in the primary and secondary motor areas (Fig. 1Q ). There were no pTDP-43-ir NCIs in the hippocampal dentate gyrus (Fig. 1R, S) . The histologic and immunohistochemical findings are summarized in Table 1 . There were no neuronal cytoplasmic or intranuclear inclusions showing immunoreactivity for p62, but not for pTDP-43 in the cerebellum and hippocampus. In addition, there were no FUS-ir neuronal and glial inclusions in the upper and lower motor neuron system. The tongue, diaphragm, and iliopsoas muscle in both patients showed severe neurogenic atrophy with fatty degeneration, while the temporal muscle in patient 2 was well preserved. In both patients, the spinal anterior roots were markedly atrophic from the cervical to the sacral levels, in contrast to the posterior roots (Fig. 1F, G) . Microscopically, marked loss of myelinated fibers was evident in the spinal anterior roots (Fig. 1T) . Neurons in the autonomic nervous system, such as the Onuf's nucleus, sympathetic ganglia, intramural ganglia in the gastrointestinal tract, and in the dorsal root ganglia of the peripheral sensory nervous system were well preserved.
DISCUSSION
The 2 patients studied here showed quite similar clinicopathologic characteristics. (i) Their age at onset was younger than the mean age at onset of patients with SALS, which ranges from 55 to 66 years (11, 12) . (ii) For several years after disease onset, the progression of their muscle weakness was comparable to that seen in a large proportion of patients with SALS. (iii) However, after introduction of TIV, the neurologic deterioration was extremely slow and disease progression appeared to be almost halted. (iv) Both patients maintained communication ability until the end of their lives. (v) Pathologically, despite their extremely long disease duration, neuronal loss was confined to the motor neuron system, and apparently mild in degree (Fig. 1) . These pathologic features were consistent with the mild clinical courses in both cases.
Because both patients showed pTDP-43-ir NCIs and GCIs in the CNS ( Fig. 1N-P ), they were diagnosed as having SALS-TDP. The number of these inclusions was extremely small. It is possible that NCIs may have disappeared in accordance with neuronal loss as Betz cells in the motor cortex and lower motor neurons in the spinal anterior horns and hypoglossal nucleus were severely depleted. However, inconsistently with this, other pyramidal neurons in the motor cortex, and lower motor neurons in the trigeminal motor nucleus, facial nucleus, and ambiguus nucleus were relatively well preserved. Therefore, we speculate that pTDP-43-ir NCIs and GCIs did not develop extensively during the disease course, or may have disappeared independently of neuronal loss. A previous report has documented the clinicopathologic features of 3 patients with SALS on TIV who maintained communication ability for approximately 30 years (7) . In those patients, neuronal degeneration was restricted to the upper and lower motor systems, and several lower motor neurons were retained, as was the case in the present patients. Although TDP-43-ir NCIs were not found in 2 of the former patients, suggesting that the pathomechanisms differed from those typical of TDP-43 proteinopathy, the other one showed a small number of TDP-43-ir NCIs restricted to certain areas, similarly to the present patients (Table 2) .
TDP-43 is a nuclear protein that regulates transcription and RNA splicing, residing in the nucleus of normal cells. In ALS, however, TDP-43 is translocated to the cytoplasm, and the protein is then aggregated, ubiquitinated and/or phosphorylated, and cleaved into smaller fragments in neuronal and glial cells (2, 3) . Numerous studies have provided evidence that both a gain of toxicity in the cytoplasm and/or a loss of function in the nucleus of TDP-43 contribute to the pathomechanisms of this disease (13, 14) . Therefore, in the present patients, the small number of TDP-43-ir NCIs might have explained the mild and spatially restricted neuronal loss.
Previously, we classified SALS into 2 subtypes based on the distribution pattern of TDP-43-ir NCIs (15): Type 1 in which NCIs are distributed in restricted areas, and type 2 in which the distribution is considerably diffuse. Type 2 can be distinguished from type 1 by the presence of TDP-43-ir NCIs in the extra-motor neuron system, including the frontotemporal cortex, hippocampal formation, neostriatum, and substantia nigra. Although the presence of such NCIs in the hippocampal dentate granule cells is a notable hallmark of type 2, a small proportion of patients show NCI distribution patterns that are atypical of type 1 or type 2. The distribution pattern of NCIs in the present 2 patients was consistent with that of type 1. This lends support to the hypothesis that types 1 and 2 represent distinct pathogenic processes that may not be influenced by long-term survival with respiratory support (15) .
With regard to long-surviving patients with SALS-TDP, we have previously reported 6 patients who survived for more than 10 years without TIV (9) ( Table 2 ). These patients shared some pathologic features with the present patients, including confinement of degeneration to the motor neuron systems and a small number of NCIs and GCIs restricted to certain areas. However, in the long-surviving patients who did not receive TIV, Betz cells and other neurons in the motor cortex were well preserved, although neuronophagia was occasionally observed in this area, and myelin pallor in the corticospinal tracts was quite mild or not evident (9) , indicating that disease progression was very slow from the onset of illness and continued until the end of life. On the other hand, unlike the former patients, the motor cortex in the present patients showed almost complete depletion of Betz cells, and other neurons were also decreased slightly (Fig. 1A-C, E) . However, ongoing neuronal degeneration was not a feature, suggesting that although the condition was serious at the initial stage, subsequent deterioration was markedly slow. In fact, muscular symptoms were evident in 2 regions upon initial examination in both of the present patients, but remained confined to one region, i.e., the upper or lower extremities for more than 4 years in the long-surviving patients without TIV (9) . Interestingly, the age at onset in the present patients and a previously reported SALS-TDP patient who maintained communication ability for a long period with TIV (7) was younger than that of most SALS patients, but not in patients without TIV (9) . Thus, the clinicopathologic pictures and underlying pathomechanisms in the present patients appeared to differ from those of the longsurviving patients without TIV. In contrast to the present patients, several ALS patients on TIV have been reported to show rapid disease progression and lose the ability to communicate in any way, thus entering a "totally locked-in state" (8) . Histologically, such patients show multisystem degeneration of the CNS and widespread distribution of pTDP-43-ir NCIs (8) . Thus, the clinicopathologic picture in patients who are "totally locked-in" appears to be distinct from that evident in the present patients. Currently, in patients with SALS, it is difficult to predict at the time of TIV initiation whether communication ability will be maintained, as was the case in the present patients, or whether a "totally locked-in state" will develop. If certain factors that would allow prognostication could be identified, this would be helpful for decision making as to whether or not TIV should be introduced.
Approximately 5%-10% of patients with ALS have a family history and mutations in several causative genes, often showing a variety of characteristic clinicopathologic features (1) . Therefore, genetic analysis would provide useful information for understanding the underlying pathomechanisms for 
Neuronal loss (*Myelin pallor): À, none; þ, mild; þþ, moderate; þþþ, severe; NCIs/GCIs: À, none; þ, rare (1-3/10 per high-power fields); NCIs, neuronal cytoplasmic inclusions; GCIs, glial cytoplasmic inclusions; pTDP-43, phosphorylated transactivation response DNA-binding protein 43 kDa; NA, not available; C, cervical cord; Th, thoracic cord; L, lumbar cord; S, sacral cord.
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SALS With Long-Term Survival patients with an atypically long clinical course. In the present patients, however, no mutations in several major genes for familial ALS were detected. The available evidence suggests that there may be a distinct subgroup of patients with SALS who can survive and maintain communication ability for an unusually long period, accompanied by very mild TDP-43 pathology. Further studies are needed to clarify the underlying pathomechanisms in this particular subgroup of SALS patients. 
*Duration from onset to introduction of TIV. TDP, transactivation response DNA-binding protein; TIV, tracheostomy and invasive ventilation; -ir, -immunoreactive; NCIs, neuronal cytoplasmic inclusions; GCIs, glial cytoplasmic inclusions; ND, not described; À, absent; þ, present.
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